WO2012036523A3 - Nouveau composé à activité antibiotique et composition antibiotique comprenant le composé - Google Patents

Nouveau composé à activité antibiotique et composition antibiotique comprenant le composé Download PDF

Info

Publication number
WO2012036523A3
WO2012036523A3 PCT/KR2011/006884 KR2011006884W WO2012036523A3 WO 2012036523 A3 WO2012036523 A3 WO 2012036523A3 KR 2011006884 W KR2011006884 W KR 2011006884W WO 2012036523 A3 WO2012036523 A3 WO 2012036523A3
Authority
WO
WIPO (PCT)
Prior art keywords
compound
antibiotic composition
antibiotically active
active compound
novel
Prior art date
Application number
PCT/KR2011/006884
Other languages
English (en)
Korean (ko)
Other versions
WO2012036523A2 (fr
Inventor
강린우
김정구
안예진
이병무
Original Assignee
건국대학교 산학협력단
대한민국(농촌진흥청장)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 건국대학교 산학협력단, 대한민국(농촌진흥청장) filed Critical 건국대학교 산학협력단
Publication of WO2012036523A2 publication Critical patent/WO2012036523A2/fr
Publication of WO2012036523A3 publication Critical patent/WO2012036523A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/54—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/46—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
    • C07C331/02—Thiocyanates
    • C07C331/14—Thiocyanates having sulfur atoms of thiocyanate groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Abstract

La présente invention concerne un nouveau composé antibiotique et une composition antibiotique comprenant le composé. Elle concerne plus spécifiquement un composé qui inhibe la synthèse de protéines chez des micro-organismes, et une utilisation du composé.
PCT/KR2011/006884 2010-09-17 2011-09-16 Nouveau composé à activité antibiotique et composition antibiotique comprenant le composé WO2012036523A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2010-0092043 2010-09-17
KR1020100092043A KR101178181B1 (ko) 2010-09-17 2010-09-17 신규한 항생활성 화합물 및 그 화합물을 포함하는 항생 조성물

Publications (2)

Publication Number Publication Date
WO2012036523A2 WO2012036523A2 (fr) 2012-03-22
WO2012036523A3 true WO2012036523A3 (fr) 2012-06-07

Family

ID=45832138

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/006884 WO2012036523A2 (fr) 2010-09-17 2011-09-16 Nouveau composé à activité antibiotique et composition antibiotique comprenant le composé

Country Status (2)

Country Link
KR (1) KR101178181B1 (fr)
WO (1) WO2012036523A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018070303A1 (fr) * 2016-10-14 2018-04-19 日産化学工業株式会社 Composition de formation de film de sous-couche de réserve comprenant un polyester contenant un groupe amide
GB201708451D0 (en) * 2017-05-26 2017-07-12 Univ Oxford Innovation Ltd Inhibitors of metallo-beta-lactamases
US20220304321A1 (en) * 2021-03-25 2022-09-29 The United States of America, as represented by the Secretary of Agriclture Germination/sprouting and fruit ripening regulators

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0075172A2 (fr) * 1981-09-17 1983-03-30 Bayer Ag N-Sulfényle benzylsulfonamides, préparation et utilisation microbicide
WO2009150144A1 (fr) * 2008-06-10 2009-12-17 Inovacia Ab Nouveaux modulateurs de gpr119
WO2011088201A1 (fr) * 2010-01-14 2011-07-21 Glaxo Group Limited Bloqueurs de canaux sodiques sensibles au potentiel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009027349A2 (fr) 2007-08-24 2009-03-05 Oryzon Genomics Sa Traitement et prévention de maladies neurodégénératives

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0075172A2 (fr) * 1981-09-17 1983-03-30 Bayer Ag N-Sulfényle benzylsulfonamides, préparation et utilisation microbicide
WO2009150144A1 (fr) * 2008-06-10 2009-12-17 Inovacia Ab Nouveaux modulateurs de gpr119
WO2011088201A1 (fr) * 2010-01-14 2011-07-21 Glaxo Group Limited Bloqueurs de canaux sodiques sensibles au potentiel

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
JI, LEI ET AL.: "Synthesis and Anti-HIV-1 Activity Evaluation of 5-Alkyl-2-alkylthio-6- (arlycarbonyl or a-cyanoarylmethyl)-3,4-dihydropyrimidin-4(3H)-ones as Novel Non- nucleoside HIV-1 Reverse Transcriptase Inhibitors", J. MED. CHEM., vol. 50, 2007, pages 1778 - 1786 *
KIM, HO SIK ET AL.: "Synthesis of Pyrazolo[3,4-b]quinoxaline Derivatives (Part II)", J. KOR. CHEM. SOC., vol. 49, 2005, pages 389 - 398 *
KUKOTA, S. N. ET AL., UKRAIN. KHIM. ZHUR., vol. 42, 1976, pages 1162 - 1166 *
MULVIHILL, MARK J. ET AL.: "1,3-Disubstituted-imidazo[1,5-a]pyrazines as insulin-like growth-factor-I receptor (IGF-IR) inhibitors", BIOORG. MED. CHEM. LETT., vol. 17, 2007, pages 1091 - 1097 *
OGURA, HARUO ET AL.: "Derivatives of Thiazolo[3,2-a]benzimidazole (Studies on Heterocyclic Compounds. II)", CHEM. PHARM. BULL., vol. 16, 1968, pages 2167 - 2171 *
WILLIAM, M.: "Commentary: Genome-based CNS drug discovery: D-Amino acid oxidase (DAAO) as a novel target for antipsychotic medications: Progress and challenges", BIOCHEMICAL PHARMACOLOGY, vol. 78, 2009, pages 1360 - 1365 *

Also Published As

Publication number Publication date
WO2012036523A2 (fr) 2012-03-22
KR101178181B1 (ko) 2012-09-19
KR20120029910A (ko) 2012-03-27

Similar Documents

Publication Publication Date Title
KR20180085042A (ko) 농업, 산업 및 다른 용도를 위한 방부제로서 비스무트-티올
UA107791C2 (en) Pesticidal compositions
MY162411A (en) Crystalline forms of a macrolide, and uses therefor
WO2012061290A3 (fr) Compositions pesticides et procédés associés
NZ618571A (en) Peptides and their use
WO2012042371A3 (fr) Composition pharmaceutique
MX2013000446A (es) Formas solidas de romdepsina y sus usos.
WO2010118866A8 (fr) Composition contenant du trehalulose, sa preparation et son utilisation
AU2011278165A8 (en) Adhesive composition including deacetylated chitosan
WO2011088027A8 (fr) Composés et procédés
MX2011008043A (es) Derivados de actagardina.
WO2013055687A3 (fr) R(+)-n-formyl-propargyl-aminoindane
WO2011057006A3 (fr) Bouillon de fermentation insecticide tiré d'actinomycètes
WO2012075015A3 (fr) Compositions pharmaceutiques orales de métronidazole
MY149433A (en) Nutritional compositions containing punicalagins
IL225440A0 (en) Compounds of cyclohexane derivatives, preparations containing them and their uses
IL225443A0 (en) A combined crystal of aprefitant and l-proline, preparations containing it and its uses
WO2012116254A3 (fr) Analogues de chrysophaentine qui inhibent la protéine ftsz
WO2012036523A3 (fr) Nouveau composé à activité antibiotique et composition antibiotique comprenant le composé
WO2012036520A3 (fr) Nouveau composé à action antibiotique et composition antibiotique le comprenant
WO2012015269A3 (fr) Composé électroluminescent organique à base de phosphaphénanthrène-carbazole et dispositif électroluminescent organique comprenant ce dernier
WO2011106630A3 (fr) Composés antimicrobiens de chrysophanéine inhibant la protéine ftsz
WO2010111421A3 (fr) Isoforme du peptide nell-1
WO2012036518A3 (fr) Nouveau composé à activité antibiotique et composition antibiotique comprenant le composé
WO2011031764A3 (fr) Composés et procédés d'utilisation s'y rapportant

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11825483

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11825483

Country of ref document: EP

Kind code of ref document: A2